Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1962 1
1963 1
1966 2
1967 3
1968 2
1969 3
1970 1
1971 1
1972 2
1974 4
1975 1
1977 7
1978 5
1979 7
1980 7
1981 11
1982 11
1983 11
1984 19
1985 30
1986 34
1987 26
1988 29
1989 27
1990 24
1991 14
1992 10
1993 18
1994 27
1995 19
1996 27
1997 16
1998 35
1999 40
2000 38
2001 43
2002 34
2003 43
2004 42
2005 47
2006 51
2007 68
2008 64
2009 79
2010 62
2011 80
2012 80
2013 97
2014 87
2015 99
2016 93
2017 124
2018 132
2019 150
2020 177
2021 191
2022 127
Text availability
Article attribute
Article type
Publication date

Search Results

2,230 results
Results by year
Filters applied: . Clear all
Page 1
Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial.
Sakamoto S, Kataoka K, Kondoh Y, Kato M, Okamoto M, Mukae H, Bando M, Suda T, Yatera K, Tanino Y, Kishaba T, Hattori N, Taguchi Y, Saito T, Nishioka Y, Kuwano K, Kishi K, Inase N, Sasaki S, Takizawa H, Johkoh T, Sakai F, Homma S; Diffuse Lung Diseases Research Group of the Ministry of Health, Labour and Welfare, Japan. Sakamoto S, et al. Among authors: hattori n. Eur Respir J. 2021 Jan 5;57(1):2000348. doi: 10.1183/13993003.00348-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32703779 Free article. Clinical Trial.
Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy.
Lin CH, Tsai PI, Lin HY, Hattori N, Funayama M, Jeon B, Sato K, Abe K, Mukai Y, Takahashi Y, Li Y, Nishioka K, Yoshino H, Daida K, Chen ML, Cheng J, Huang CY, Tzeng SR, Wu YS, Lai HJ, Tsai HH, Yen RF, Lee NC, Lo WC, Hung YC, Chan CC, Ke YC, Chao CC, Hsieh ST, Farrer M, Wu RM. Lin CH, et al. Among authors: hattori n. Brain. 2020 Dec 5;143(11):3352-3373. doi: 10.1093/brain/awaa279. Brain. 2020. PMID: 33141179 Free PMC article.
The Gut-Brain Axis.
Hattori N, Yamashiro Y. Hattori N, et al. Ann Nutr Metab. 2021;77 Suppl 2:1-3. doi: 10.1159/000512226. Epub 2021 Jan 6. Ann Nutr Metab. 2021. PMID: 33406517 Free article. No abstract available.
Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study.
Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A, Schulte C, Grover S, Mohamed O, Portugal B, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Duga S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Kawamura Y, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BPC, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Correia Guedes L, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Hellberg C, Clarke CE, Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Krüger R, Gasser T, Sharma M, Elbaz A; Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (Courage-PD) Consortium. Domenighetti C, et al. Among authors: hattori n. Mov Disord. 2022 Apr;37(4):857-864. doi: 10.1002/mds.28902. Epub 2022 Jan 8. Mov Disord. 2022. PMID: 34997937
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: hattori n. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Clinical Trial.
2,230 results